Melis M, Sanna F, Argiolas A
Brain Sci. 2022; 12(7).
PMID: 35884633
PMC: 9312911.
DOI: 10.3390/brainsci12070826.
Kiss B, Kramos B, Laszlovszky I
Front Psychiatry. 2022; 13:785592.
PMID: 35401257
PMC: 8987915.
DOI: 10.3389/fpsyt.2022.785592.
Kehr J, Wang F, Ichinose F, Yoshitake S, Farkas B, Kiss B
Front Psychiatry. 2022; 12:801641.
PMID: 35095615
PMC: 8789685.
DOI: 10.3389/fpsyt.2021.801641.
Kiss B, Laszlovszky I, Kramos B, Visegrady A, Bobok A, Levay G
Biomolecules. 2021; 11(1).
PMID: 33466844
PMC: 7830622.
DOI: 10.3390/biom11010104.
Czoty P, John W, Newman A, Nader M
Alcohol. 2018; 69:1-5.
PMID: 29550583
PMC: 5904012.
DOI: 10.1016/j.alcohol.2017.10.003.
Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.
Kostrzewa R, Nowak P, Brus R, Brown R
Neurochem Res. 2015; 41(1-2):183-92.
PMID: 26547196
DOI: 10.1007/s11064-015-1757-0.
Electrophysiological association of spontaneous yawning and swallowing.
Ertekin C, Bulbul N, Uludag I, Tiftikcioglu B, Arici S, Gurgor N
Exp Brain Res. 2015; 233(7):2073-80.
PMID: 25929548
DOI: 10.1007/s00221-015-4278-9.
Pathological yawning as an ictal seizure manifestation in the elderly.
Nicotra A, Khalil N, Owbridge P, Hakda M, Beitverda Y
BMJ Case Rep. 2012; 2012.
PMID: 23076687
PMC: 4543004.
DOI: 10.1136/bcr-01-2012-5618.
On yawning and its functions.
Baenninger R
Psychon Bull Rev. 2011; 4(2):198-207.
PMID: 21331826
DOI: 10.3758/BF03209394.
Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats.
Li S, Collins G, Paul N, Grundt P, Newman A, Xu M
Behav Pharmacol. 2010; 21(3):171-81.
PMID: 20463460
PMC: 3103047.
DOI: 10.1097/FBP.0b013e32833a5c68.
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.
Collins G, Newman A, Grundt P, Rice K, Husbands S, Chauvignac C
Psychopharmacology (Berl). 2007; 193(2):159-70.
PMID: 17393143
PMC: 3094913.
DOI: 10.1007/s00213-007-0766-3.
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins G, Witkin J, Newman A, Svensson K, Grundt P, Cao J
J Pharmacol Exp Ther. 2005; 314(1):310-9.
PMID: 15833897
PMC: 1201434.
DOI: 10.1124/jpet.105.085472.
[Physiology and pathophysiology of erectile dysfunction. A modern contrivance?].
Hauri D
Urologe A. 2004; 43(11):1423-9.
PMID: 15517144
DOI: 10.1007/s00120-004-0674-7.
Effects of adenosine agents on apomorphine-induced yawning in rats.
Zarrindast M, Fatehi F
Psychopharmacology (Berl). 1995; 122(3):292-6.
PMID: 8748398
DOI: 10.1007/BF02246550.
Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats.
Zharkovsky A, Moisio J, Kivastik T, Ahtee L
Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(5):478-82.
PMID: 8100615
DOI: 10.1007/BF00166738.
Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist.
Ferrari F, Pelloni F, Giuliani D
Psychopharmacology (Berl). 1993; 113(2):172-6.
PMID: 7855178
DOI: 10.1007/BF02245694.
Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning?.
Nickolson V, van Riezen H, Van Delft A
Psychopharmacology (Berl). 1984; 83(2):188-93.
PMID: 6431472
DOI: 10.1007/BF00429733.
Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.
Clark D, Hjorth S, Carlsson A
J Neural Transm. 1985; 62(1-2):1-52.
PMID: 3894582
DOI: 10.1007/BF01260414.
Conditioning of behavioural effects produced by an intermediate dose of apomorphine: hypokinesia, ptosis and stereotypies.
Nowak K, Kuschinsky K
Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(3):262-6.
PMID: 3683596
DOI: 10.1007/BF00172676.
Studies on interactions between conditioned and unconditioned behavioural responses to apomorphine in rats.
Moller H, Nowak K, Kuschinsky K
Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(6):673-9.
PMID: 3627283
DOI: 10.1007/BF00166985.
